Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Proteomics of a conundrum: thoughts on addressing the aetiology vs. progression of Multiple Sclerosis.
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
Asynchrony in Executive Networks Predicts Cognitive Slowing in Multiple Sclerosis.
Ultrasound detection of knee joint degeneration in patients with multiple sclerosis.
The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis.
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
[The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Artificial reproductive techniques in multiple sclerosis.
Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children.
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin?
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Effects of isoxazolo-pyridinone 7e, a potent activator of the nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assays.
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review.
Proteome analysis of post-transplantation recovery mechanisms of an EAE model of multiple sclerosis treated with embryonic stem cell-derived neural precursors.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Pediatric Inflammatory Diseases. Part II: Acute Post-Infectious Immune Disorders.
Pages
« first
‹ previous
…
516
517
518
519
520
521
522
523
524
…
next ›
last »